Promacta (Eltrombopag Olamine)
Promacta
(Brand Option)
Select Quantity
$1,150.00 ($0.07 per tablet)
$3,420.25 ($0.07 per tablet)
$1,899.00 ($0.07 per tablet)
Eltrombopag Olamine
(Generic Alternative)
This generic medication is not available at the moment.
Lower Costs and Easier Access
Enjoy the Canadian benefits of both.
You can buy Promacta from Canada on DoctorSolve.com without leaving the comfort of your home. DoctorSolve™ has been a trustworthy choice for online pharmacy needs in the United States since 1999.
We offer competitive Canadian prices for Promacta, helping you save thousands of dollars on your medication each year. DoctorSolves™ reputation for exceptional service is backed by a remarkable 4.8/5 customer rating and 655+ positive reviews.
DoctorSolve™ is verified by Canadian International Pharmacy Association (CIPA) and International Pharmacy Association of British Columbia (IPABC). We prioritize your health by requiring a valid prescription from a healthcare provider, ensuring Promacta is appropriate for your condition.
If you prefer speaking to a support staff, call +1-866-732-0305 to order Promacta or fax your prescription to 1-877-251-1650. Our support staff are prompt and will answer all your queries professionally.
Promacta is indicated for the following purposes:
- It is used to increase the number of platelets in adults and children one year of age and older who have chronic immune thrombocytopenia (ITP) and have not been helped or cannot be treated with other treatments, including medications or surgery to remove the spleen.
- It is also used to increase the number of platelets in people who have hepatitis C so that they can receive treatment for the viral infection without the risk of bleeding.
- In addition, Promacta is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia, and for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
Do’s
- Take Promacta by mouth as directed by your healthcare provider, usually once daily.
- Ensure to take it at the same time each day to get the most benefit from it.
- Take Promacta without a meal or with a meal low in calcium (50 milligrams or less).
- Take it at least 2 hours before or 4 hours after taking any products that contain magnesium, aluminium, or calcium-rich foods.
- Follow the manufacturer's Instructions for Use carefully if using the suspension powder.
- Use the provided mixing bottle to mix each dose with cool or cold water and give this medication right away.
- Use the provided special measuring device (oral syringe) to prepare and give each dose.
- Get a blood test once a week for at least 4 weeks to check your platelet count after your last dose of Promacta, as ordered by your healthcare provider.
- Consult your healthcare provider if you are of East-Asian/Southeast-Asian descent or have liver problems, as you may need a lower dose.
- Ask your healthcare provider if you should continue taking your other medications for ITP (such as corticosteroids, azathioprine, danazol) while using Promacta.
- Store Promacta tablets and Promacta for oral suspension as directed by the manufacturer. Follow the storage instructions to ensure the medication's effectiveness.
Don’ts
- Do not split, chew, or crush Promacta tablet before taking it.
- Do not mix Promacta tablets with food or liquid.
Common Side Effects:
- Hemorrhage
- Nausea
- Fatigue
- Cataracts
Not all of these side effects may occur, and if they do, they may need medical attention. If you experience any side effects that bother you or do not go away, talk with your healthcare provider.
In clinical studies, hemorrhage was the most common serious adverse reaction, and most hemorrhagic reactions followed the discontinuation of Promacta.
Platelet counts generally increased within 1 to 2 weeks after starting Promacta and decreased within 1 to 2 weeks after discontinuing it. Excessive platelet count responses or important liver test abnormalities may necessitate discontinuation of Promacta. CBCs with differentials, including platelet counts, should be obtained weekly for at least 4 weeks following discontinuation of Promacta.
Promacta may increase the risk for liver problems in people with chronic hepatitis C when taken with certain medications. Discuss this risk with a healthcare provider.
Certain medicines may keep Promacta from working correctly. Consult a healthcare provider if unsure about the interaction of specific medications.
If new cytogenetic abnormalities are observed, discontinuation of Promacta should be considered.
This is not an exhaustive list of warnings and precautions associated with Promacta. Always consult a healthcare provider for personalized advice and guidance regarding the use of Promacta and its associated warnings and precautions.
Brand Name: | Promacta |
---|---|
Generic name: | Eltrombopag Olamine |
Other Names: | Revolade |
Strength(s): | 25mg, 50mg |
Quantities Available: | 14, 42 |
Formulation: | Tablet |